EQSNews: ActiTrexx GmbH
/ Key words: Study
ActiTrexx treats first patient with novel regulatory T cell therapy against GraftversusHost Disease
19.03.2024 / 10:00 CET/CEST
The issuer is solely responsible for the content of this announcement.
ActiTrexx treats first patient with novel regulatory T... Lire le communiqué |